Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emerald completes latest financing, launches emerald cloud lab
Founders Fund and Max Levchin, a PayPal co-founder, led this latest financing along with investment from Schooner Capital. The company also announced the release of its first product:
Founders Fund and Max Levchin, a PayPal co-founder, led this latest financing along with investment from Schooner Capital. The company also announced the release of its first product:
The investigational vaccine is being co-developed by GlycoVaxyn AG and Janssen Pharmaceuticals Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The first-in-human clinical study
The data demonstrate that patients who continued Gattex treatment beyond two years achieved clinically meaningful reductions in parenteral support requirements, including volume and days off, with 13 out
"For quite some time, physicians have relied on Cordran® Lotion and Cordran® Cream to help treat a variety of skin conditions. With the launch of Cordran Ointment, physicians
Qudexy XR is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile. It was approved by the U.S. Food and Drug Administration in
This recall is a precautionary measure based on the company’s investigation of visible particulate matter found in a small number of COUMADIN FOR INJECTION unreleased samples. Bristol-Myers Squibb
During this collaboration, a focused research team at Roche will work with Stratos scientists to support the development of efficient, low-cost sample preparation methods for DNA Xpandomers and
The CHMP’s positive opinion will now be reviewed by the European Commission (EC). The decision on whether to approve Eliquis for this indication will be made by the
KALYDECO was first approved in Europe in July 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation, which
"Diabetes is a growing health concern worldwide and this milestone brings us one step closer to being able to offer patients and physicians in the European Union a